Evaluation of Hyponatremia Management Pathway

Authors

Mahmoud Ammar PharmD, Department of Pharmacy Services, Yale New Haven Hospital, New Haven, CT, USA.
Jonathan M. Siner, 5 Department of Internal Medicine, Section of Pulmonary, Critical Care, & Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Judson Mary, Yale New Haven Health/Bridgeport Hospital
Christopher Winterbottom, Department of Pulmonology and Critical Care, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA.

Document Type

Conference Proceeding

Abstract

Society of Critical Care Medicine's (SCCM) 2025 Critical Care Congress:

Evaluation of Hyponatremia Management Pathway Implementation in a Large Academic Health System

Submission Number: 1894079

Patients with severe hyponatremia managed using the Care Signature pathway were more likely to receive hypertonic saline and had lower mortality rates compared to those not managed with the pathway. These results suggest that the pathway can improve clinical outcomes and reduce resource use. Further studies are needed to evaluate its impact on other patients’ outcomes and long-term effectiveness.

Publication Date

2-2025

Recommended Citation

Ammar, Mahmoud PharmD; Siner, Jonathan M.; Mary, Judson; and Winterbottom, Christopher, "Evaluation of Hyponatremia Management Pathway" (2025). Abstracts. 11.
https://scholar.bridgeporthospital.org/abstract_presentations/11